<DOC>
	<DOC>NCT01679522</DOC>
	<brief_summary>To compare the feasibility, safety, and efficacy between single-port and four-port laparoscopic surgical staging in patients with early stage endometrial cancer.</brief_summary>
	<brief_title>Feasibility Study of Laparoendoscopic Single Site Surgical Staging for Endometrial Cancer</brief_title>
	<detailed_description />
	<mesh_term>Endometrial Neoplasms</mesh_term>
	<criteria>Previously untreated, histologically confirmed endometrial cancer Presumed FIGO stage 1 Endometrioid adenocarcinoma patient who is planned to undergo surgical staging adequate oran function 1. WBC &gt; 3000 cells/mcl 2. Platelets &gt; 100000/mcl 3. Creatinine &lt; 2.0 mg/dL 4. Bilirubin &lt; 1.5 * normal and SGOT or SGPT &lt; 3 * normal American Society of Anesthesiologists Physical Status III Eastern Cooperative Oncology Group performance status 02 Patients who have signed an approved Informed Consent Uncontrolled medical disease Active infectious disease requiring antibiotics Previous pelvic radiation therapy Pregnant and lactating woman Patient who requires additional surgical procedures which are not necessary for surgical staging of endometrial cancer</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>endometrial cancer</keyword>
	<keyword>laparoscopic surgical staging</keyword>
	<keyword>single-port</keyword>
	<keyword>four-port</keyword>
</DOC>